| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.0065 | 0.9 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.012 | 1 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | -0.0087 | 1 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | 0.0099 | 1 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |